Related Experiment Video
Updated: Jun 13, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Tumor immunoediting by NKp46
Moran Elboim1, Roi Gazit, Chamutal Gur
1Lautenberg Center for General and Tumor Immunology, Institute for Medical Research Israel Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Abstract:
NK cells interact with a wide variety of hazardous cells including pathogen-infected and tumor cells. NKp46 is a specific NK killer receptor that recognizes various influenza hemagglutinins and unknown tumor ligands. It was recently shown that NKp46 plays a significant role in the in vivo eradication of tumor cells; however, the role played by NKp46 in vivo with regard to tumor development is still unclear. In this study, we used the 3-methylcholanthrene (MCA)-induced fibrosarcoma model in NKp46-deficient mice to test the NKp46 recognition of carcinogen-induced tumors. We show that although the rate of MCA-induced tumor formation was similar in the presence and in the absence of NKp46, the expression of its unknown ligands was NKp46 dependent. The unknown NKp46 ligands were nearly absent in tumors that originated in wild-type mice, whereas they were detected in tumors that originated in the NKp46-deficient mice. We demonstrate that the interactions between NKp46 and its MCA tumor-derived ligands lead to the secretion of IFN-gamma but not to the elimination of the MCA-derived tumor cells. In addition, we show that the in vivo growth of MCA-derived tumor cells expressing high levels of the NKp46 ligands is NKp46 and IFN-gamma dependent. Thus, we present in this study a novel NKp46-mediated mechanism of tumor editing.
Insights
Natural killer (NK) cells and NKp46 receptors are crucial in tumor surveillance. This study reveals NKp46-dependent tumor editing in mice, where NKp46 interaction with tumor ligands promotes IFN-gamma secretion and controls tumor growth.
Area of Science:
- Immunology
- Cancer Biology
- Cellular and Molecular Immunology
Background:
- Natural killer (NK) cells are critical for identifying and eliminating abnormal cells, including tumor cells.
- NKp46 is a key activating receptor on NK cells, recognizing various ligands on target cells.
- The precise role of NKp46 in the in vivo development of carcinogen-induced tumors remains incompletely understood.
Purpose of the Study:
- To investigate the role of NKp46 in the recognition and development of 3-methylcholanthrene (MCA)-induced fibrosarcomas.
- To elucidate the mechanism by which NKp46 influences tumor progression in vivo.
Main Methods:
- Utilized a 3-methylcholanthrene (MCA)-induced fibrosarcoma model in NKp46-deficient mice.
- Analyzed the expression of NKp46 ligands on tumors derived from wild-type and NKp46-deficient mice.
- Assessed the impact of NKp46-ligand interactions on cytokine secretion (IFN-gamma) and tumor cell elimination.
Main Results:
- Tumor formation rates were similar in NKp46-deficient and wild-type mice.
- Expression of NKp46 ligands was dependent on NKp46, with higher detection in tumors from NKp46-deficient mice.
- NKp46-ligand interactions led to IFN-gamma secretion but not direct tumor cell elimination.
- In vivo tumor growth was dependent on NKp46 and IFN-gamma when NKp46 ligands were highly expressed.
Conclusions:
- NKp46 plays a role in tumor editing, a process distinct from direct elimination.
- The interaction between NKp46 and its ligands on carcinogen-induced tumors influences the tumor microenvironment via IFN-gamma.
- This study uncovers a novel NKp46-mediated mechanism regulating tumor growth and progression.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Abnormal Proliferation
The Tumor Microenvironment
The Tumor Microenvironment
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

